D E Furst, F C Breedveld, J R Kalden, J S Smolen, G R Burmester, J Sieper, P Emery, E C Keystone, M H Schiff, P Mease, P L C M van Riel, R Fleischmann, M H Weisman, and M E Weinblatt
Updated consensus statement on biological agents for the treatment of rheumatic diseases
Ann Rheum Dis 2007;66 iii2-iii22
Fleischmann R, Iqbal I.
Risk: benefit profile of etanercept in elderly patients with rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis.
Drugs Aging. 2007;24(3):239-54.
Dhillon S, Lyseng-Williamson KA, Scott LJ
Etanercept: a review of its use in the management of rheumatoid arthritis
Drugs. 2007;67(8):1211-41
Fleischmann R, Baumgartner SW, Weisman MH, Liu T, White B, Peloso P.
Long term safety of etanercept in elderly subjects with rheumatic diseases.
Ann Rheum Dis. 2006 Mar;65(3):379-84
Davis JC.
Understanding the role of tumor necrosis factor inhibition in ankylosing spondylitis.
Semin Arthritis Rheum. 2005 Feb;34(4):668-77.
Horneff G, Schmeling H, Biedermann T, Foeldvari I, Ganser G, Girschick HJ, Hospach T, Huppertz HI, Keitzer R, Küster RM, Michels H, Moebius D, Rogalski B, Thon A;
The German etanercept registry for treatment of juvenile idiopathic arthritis.
Ann Rheum Dis. 2004 Dec;63(12):1638-44.
Braun J, Baraliakos X, Brandt J, Sieper J
Therapy of ankylosing spondylitis. Part II: biological therapies in the spondyloarthritides
Scand J Rheumatol. 2005;34(3):178-90
Fleischmann RM, Iqbal I, Stern RL.
Considerations with the use of biological therapy in the treatment of rheumatoid arthritis.
Expert Opin Drug Saf. 2004 Sep;3(5):391-403.
Genovese MC, Kremer JM.
Treatment of rheumatoid arthritis with etanercept.
Rheum Dis Clin North Am. 2004 May;30(2):311-28,
Braun J, Brandt J, Listing J, Rudwaleit M, Sieper J
Biologic therapies in the spondyloarthritis: new opportunities, new challenges
Curr Opin Rheumatol. 2003; 15(4):394-407
Brandt J, Sieper J, Braun J.
Treatment of ankylosing spondylitis and undifferentiated spondyloarthritis with TNF alpha-antagonists
Z Rheumatol. 2003; 62(3):218-27
Davis JC Jr.
The role of etanercept in ankylosing spondylitis
Clin Exp Rheumatol. 2002 Nov-Dec;20(6 Suppl 28):S111-5
Braun J, de Keyser F, Brandt J, Mielants H, Sieper J, Veys E.
New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti-tumor necrosis factor therapy
Curr Opin Rheumatol. 2001 Jul;13(4):245-9
Druckversion
